High Systemic Levels of the Cytokine-Inducing HMGB1 Isoform Secreted in Severe Macrophage Activation Syndrome

Molecular Medicine - United States
doi 10.2119/molmed.2014.00183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Successful Use of Infliximab in Macrophage Activation Syndrome With Severe CNS Affection

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Features, Treatment and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Cytokine and Chemokine Levels in Patients With Severe Fever With Thrombocytopenia Syndrome Virus

PLoS ONE
Multidisciplinary
2012English

AB0497 Six Cases of Macrophage Activation Syndrome as Presenting Manifestation of Systemic Lupus Erythematosus

2017English

Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis

Arthritis Care and Research
Rheumatology
2018English

IV Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of COVID19

ACR Open Rheumatology
2020English

Macrophage Activation by Factors Released From Acetaminophen-Injured Hepatocytes: Potential Role of HMGB1

Toxicology and Applied Pharmacology
ToxicologyPharmacology
2011English

AB0974 Etanercept Treatment for a Patient With Refractory Macrophage Activation Syndrome in Juvenile Systemic Lupus Erythematous

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy